Chris Garabedian’s incubator leads Series A funding for gene therapy manufacturer/developer combo
Back in December, longtime industry investor Chris Garabedian helped launch a $210 million VC fund for early-stage biotechs. On Tuesday, […]
XeRo
Posts by XeRo
PRESS: Endpoints News
Back in December, longtime industry investor Chris Garabedian helped launch a $210 million VC fund for early-stage biotechs. On Tuesday, […]
PRESS: Xconomy
Forge Biologics has something rare for most early-stage biotech startups: revenue from customers. Now it has $40 million to expand […]
Forge Bio’s Combo Model for Gene Therapies Attracts $40M in Funding
Forge Biologics has something rare for most early-stage biotech startups: revenue from customers. Now it has $40 million to expand […]
Read More… from Forge Bio’s Combo Model for Gene Therapies Attracts $40M in Funding
PRESS: Fierce Biotech
Six months after departing Abeona, Tim Miller, Ph.D., is on his next chapter: Forge Biologics, a gene therapy biotech that’s […]
‘Gene therapy engine’ Forge debuts with $40M and Tim Miller at the helm
Six months after departing Abeona, Tim Miller, Ph.D., is on his next chapter: Forge Biologics, a gene therapy biotech that’s […]
Read More… from ‘Gene therapy engine’ Forge debuts with $40M and Tim Miller at the helm